Phathom Pharmaceuticals Inc (PHAT) — Cash Flow-to-Debt Ratio
Phathom Pharmaceuticals Inc (PHAT) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of $-14.12 Million could theoretically repay 0% of its total liabilities ($662.82 Million) in one year. See Phathom Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Phathom Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Phathom Pharmaceuticals Inc across 7 annual periods. Also explore PHAT net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Phathom Pharmaceuticals Inc (2018–2024)
Year-by-year debt coverage analysis for Phathom Pharmaceuticals Inc. For market capitalisation and broader financial context, see market value of Phathom Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.42x | $-266.77 Million | $631.90 Million | ▼ -49.3% |
| 2023 | -0.28x | $-137.58 Million | $486.60 Million | ▲ +53.8% |
| 2022 | -0.61x | $-146.53 Million | $239.62 Million | ▲ +51.7% |
| 2021 | -1.27x | $-148.46 Million | $117.28 Million | ▼ -83.2% |
| 2020 | -0.69x | $-69.69 Million | $100.84 Million | ▲ +44.7% |
| 2019 | -1.25x | $-36.51 Million | $29.22 Million | ▼ -167.2% |
| 2018 | -0.47x | $-1.02 Million | $2.19 Million | — |